(S1 (S (NP (NNP Recurrent) (NNP Doc_448423_10_33_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_448423_50_67_Chemical) (NN therapy)) (CC and) (NP (NN Doc_448423_80_109_Disease))))) (. .)))
(S1 (S (NP (NN Case)) (VP (VBP report)) (. .)))
(S1 (S (NP (NP (NNP Doc_448423_124_149_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_448423_151_155_Chemical)) (-RRB- -RRB-))) (VP (AUX has) (VP (AUX been) (VP (VBN used) (S (VP (TO to) (VP (VB prevent) (NP (NN rebleeding)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNP Doc_448423_210_233_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_448423_235_238_Disease)) (-RRB- -RRB-)))))))))))) (. .)))
(S1 (S (SBAR (IN Although) (S (NP (DT this) (NN agent)) (VP (AUX does) (VP (VB decrease) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN rebleeding)))))))) (, ,) (NP (JJ several) (NNS reports)) (VP (AUX have) (VP (VBN described) (NP (NP (JJ Doc_448423_335_345_Disease) (NNS complications)) (PP (IN of) (NP (JJ Doc_448423_363_367_Chemical) (NN therapy)))))) (. .)))
(S1 (S (NP (DT These) (NNS complications)) (VP (AUX have) (VP (VBN included) (NP (NP (JJ clinical) (NN deterioration)) (CC and) (NP (NNP Doc_448423_438_470_Disease))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNP Doc_448423_488_491_Disease)) (, ,) (NP (NP (JJ arteriolar) (CC and) (JJ capillary) (NN fibrin) (NN Doc_448423_525_532_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ fibrinolytic) (NNS syndromes)) (VP (VBN treated) (PP (IN with) (NP (NNP Doc_448423_586_590_Chemical))))))))) (, ,)) (CC or) (NP (JJ other) (NNP Doc_448423_601_625_Disease)))))))) (. .)))
(S1 (S (SBAR (IN Since) (S (NP (JJ intravascular) (NN fibrin) (NNP Doc_448423_654_661_Disease)) (VP (AUX are) (ADVP (RB often)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ fibrinolytic) (NNS disorders))))))))) (, ,) (NP (NNP Doc_448423_722_726_Chemical)) (VP (MD should) (RB not) (VP (AUX be) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (NNP fibrin) (NNP Doc_448423_782_789_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNP Doc_448423_807_845_Disease)) (CC or) (NP (JJ other) (`` ``) (NX (NNP Doc_448423_856_882_Disease)))))))))))))) (. .) ('' '')))
(S1 (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (JJ subtotal) (NN Doc_448423_916_926_Disease)) (PP (IN of) (NP (DT the) (NN kidney))) (PP (JJ due) (TO to) (NP (NNP Doc_448423_948_983_Disease))))) (. .)))
(S1 (S (NP (DT This) (NN occlusion)) (VP (VBD occurred) (PP (IN after) (NP (JJ Doc_448423_1015_1019_Chemical) (NN therapy))) (PP (IN in) (NP (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNP Doc_448423_1046_1049_Disease)))) (CC and) (NP (NP (JJ histopathological) (NN documentation)) (PP (IN of) (NP (JJ recurrent) (NNP Doc_448423_1099_1102_Disease))))))) (. .)))
(S1 (S (NP (DT The) (JJ corresponding) (JJ clinical) (NN event)) (VP (AUX was) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ marked) (NN Doc_448423_1165_1177_Disease)) (CC and) (NP (JJ abrupt) (JJ neurological) (NN deterioration)))))) (. .)))
